Diphtheria, Pertussis and Tetanus (DTP) Vaccine Market is poised to register a CAGR of 5.1% during the forecast period 2022 to 2028.

The first immunisation given to infants is often the DTaP (Diphtheria, Tetanus, and Acellular Pertussis) vaccine at two months of age. The capital "D" and "P" in DTaP refer to the higher amounts of Diphtheria and Pertussis antigens compared to Tdap products. Three contagious human diseases—diphtheria, tetanus, and pertussis—are prevented by the diphtheria, pertussis, and tetanus (DPT) vaccination. To generate acquired immunity against Diphtheria, Pertussis, and Tetanus, these vaccines are administered either during childhood or during middle life. DTP, also known as diphtheria, tetanus, and pertussis, are severe illnesses brought on by the bacteria. Diphtheria, tetanus, and pertussis vaccines are combined and administered intramuscularly as the DTP vaccine. In order to successfully immunise children up to the age of seven against Diphtheria, Tetanus, and Pertussis (whooping cough), diphtheria and tetanus toxoids and the pertussis vaccine are advised concurrently. This trend has primarily been caused by an increase in demand for combination vaccinations that are tetravalent and then pentavalent. The funding provided by GAVI (Global Alliance for Vaccines and Immunizations) for further DTP-containing vaccines has played a significant role in driving the rising demand for combination products. The pertussis vaccine market is expected to increase rapidly due to the high birth rate and rising demand for the vaccine, which will favourably affect the worldwide Diphtheria, Pertussis and Tetanus (DTP) Vaccine market. Other factors anticipated to contribute to market expansion include a rise in the frequency of DPT cases, improvements in vaccine administration systems, the creation of technologically sophisticated vaccines, and government initiatives

FutureWise Market Research has instantiated a report that provides an intricate analysis of Diphtheria, Pertussis and Tetanus (DTP) Vaccine Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Diphtheria, Pertussis and Tetanus (DTP) Vaccine Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Diphtheria, Pertussis and Tetanus (DTP) Vaccine Market:
• AJ Vaccines
• Bionet-Asia
• GlaxoSmithKline plc (GSK)
• Johnson & Johnson
• Massbiologics
• Meiji Holdings Co., Ltd. (KM biologics Co., Ltd.)
• Merck & Co., Inc
• Panacea Biotec Ltd.
• Sanofi
• Serum Institute of India Pvt. Ltd.
 (Note: The list of the major players will be updated with the latest market scenario and trends)

Diphtheria, Pertussis and Tetanus (DTP) Vaccine Market Segmentation:
By Product Type
• DTaP Vaccine
• TD Vaccine
• Tdap Vaccine

By Age Group  
• Adult
• Pediatrics

By End User
• Hospitals
• Clinics
• Vaccination Centers

By Region
• North America
• Asia-Pacific
• Latin America
• Middle East and Africa

Diphtheria, Pertussis and Tetanus (DTP) Vaccine Market Sample Video:

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Diphtheria, Pertussis and Tetanus (DTP) Vaccine Market By Product Type, By Age Group, By End User and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com


Need Assistance


UK : +44 141 628 9353
US : +1 347 709 4931


Contact Sales

What you get

  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included

  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics